TABLE G-1 Summary of the Top Reporta Findings and Recommendations by Deputy Secretary of Defense Focus Areas

Focus Area



1—Vaccines to protect service members against biological warfare threats as well as infectious diseases.

Vaccines for biological warfare defense and protection against endemic diseases are essential enablers of force projection.

Combine programs from discovery to production.

2—A comparison of current Department efforts with best business practices in the biologics industry, and if/how the Department can leverage the best aspects of the private sector programs from industry.

Current Department efforts do not meet industry best practices:

  • Diffuse management and fragmented lines of responsibility

  • Inadequate scientific oversight

  • Inadequate program integration from discovery through licensure

  • Inadequate resources to meet goals

Adopt integrated approach utilizing:

  • Management and development skills of industry

  • Accountable, lean DoD management structure

  • Strong technical guidance and personnel

  • Government-owned, contractor operated (GOCO)

3—A determination of whether the DoD program requires acquisition processes unique from normal departmental acquisition procedures.

Vaccine acquisition processes are different from weapons system acquisition processes and success requires different procedures.

  • Strong technical input imperative

  • Workforce

  • Management

  • Stable, long-range funding for vaccine life cycle

  • Reprogramming authority

4—The development of recommendations for how the Department should best develop and oversee a vaccine acquisition production program.

DoD acquisition of vaccine production management practices are generally contrary to industry best practices.

  • Combined, integrated industry acquisition model

  • Focused and streamlined organization

  • Segregated, Office of Secretary of Defense-sponsored funding

  • Incentivized industry involvement (with GOCO)

  • DoD, Executive Branch, and congressional support to remove impediments and provide necessary incentives

aSee footnote 1.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement